SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload (Q40832729)

24 September 2017

title

SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload (English)

1 reference

24 September 2017

Gang Wu

1

1 reference

24 September 2017

Yu Liu

2

1 reference

24 September 2017

He Huang

3

1 reference

24 September 2017

Yanhong Tang

4

1 reference

24 September 2017

Wanli Liu

5

1 reference

24 September 2017

Yang Mei

6

1 reference

24 September 2017

Nian Wan

7

1 reference

24 September 2017

Xiaoxiong Liu

8

1 reference

24 September 2017

Congxin Huang

9

1 reference

24 September 2017

publication date

15 June 2015

1 reference

24 September 2017

published in

Cardiovascular Research

1 reference

24 September 2017

volume

107

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

203-215

1 reference

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Interferon regulatory factor 1 is required for cardiac remodeling in response to pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

SH2B regulation of growth, metabolism, and longevity in both insects and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Neuronal SH2B1 is essential for controlling energy and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

The Rac and Rho hall of fame: a decade of hypertrophic signaling hits

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Disruption of the SH2-B gene causes age-dependent insulin resistance and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Insulin receptor substrates Irs1 and Irs2 coordinate skeletal muscle growth and metabolism via the Akt and AMPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

SH2-B is required for both male and female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Dickkopf-3 attenuates pressure overload-induced cardiac remodelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Impaired JAK2-induced activation of STAT3 in failing human myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Human SH2B1 mutations are associated with maladaptive behaviors and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Kinase activation through dimerization by human SH2-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Critical role of the Src homology 2 (SH2) domain of neuronal SH2B1 in the regulation of body weight and glucose homeostasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

SH2-B promotes insulin receptor substrate 1 (IRS1)- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Identification of SH2B2beta as an inhibitor for SH2B1- and SH2B2alpha-promoted Janus kinase-2 activation and insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Differential role of SH2-B and APS in regulating energy and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

SH2B1 regulation of energy balance, body weight, and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma messenger ribonucleic acid levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Nutritional regulation of genome-wide association obesity genes in a tissue-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Expression of new loci associated with obesity in diet-induced obese rats: from genetics to physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Progress and prospects in rat genetics: a community view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

Impact of genomics on research in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

TALENs: a widely applicable technology for targeted genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

The role of the Grb2–p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV170

21 January 2018

Identifiers

DOI

10.1093/CVR/CVV170

1 reference

24 September 2017

1 reference